Solid Biosciences Inc.
SLDB· Nasdaq
Released Nov 5, 2020, before the open
10-Q filed Nov 5, 2020, 36 days after period end · 0001564590-20-050874
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$21.25M | -$29.26M | -$19.02M | -$13.51M |
| EPS Diluted |
Solid Biosciences Inc. · CIK 1707502 · Engraved from SEC EDGAR
| -$0.44 |
| -$0.67 |
| -$0.55 |
| -$0.79 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.